| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Medical technology | |
| #4 | Foods and drinks | |
| #5 | Measurement | |
| #6 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Microorganisms | |
| #4 | Object sterilising | |
| #5 | Enzymes | |
| #6 | Measuring microorganism processes | |
| #7 | Unspecified technologies | |
| #8 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Shlieout George | 12 |
| #2 | Frink Martin | 8 |
| #3 | Sczesny Frithjof | 8 |
| #4 | Blume Heinz | 6 |
| #5 | Rust Michael | 6 |
| #6 | Onken Jens | 4 |
| #7 | Rupp Christopher | 4 |
| #8 | Koelln Claus-Juergen | 4 |
| #9 | Koelln Claus-Jürgen | 4 |
| #10 | Rueffer Frauke-Regina | 3 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020012243A2 | Pharmaceutical composition containing a peptide | |
| AU2005244483A1 | Essential fatty acids in the prevention and/or treatment of depression in patients with coronary heart or artery disease | |
| AU2004283047A1 | Pharmaceutical composition comprising a selective I1 imidazoline receptor agonist and an angiotensin II receptor blocker |